NYBC has partnered with the Hemophilia Services Consortium, Inc., to provide pharmacy services to patients with bleeding disorders enrolled in select Hemophilia Treatment Centers (HTCs).
We provide a wide-range of consultative services in hospitals and through special products and services to patients with bleeding disorders.
CCS is your research, development and manufacturing partner for your autologous and allogeneic cell therapies. From start to finish. Your ideas. Our world-class expertise.